Company / SG&A Expense
Steris SG&A Expense History
FY2018-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.3B
FY2026
5-year range
$716.7M / $1.3B
FY2022-FY2026
Trend
+14.8%
vs FY2025
Sector context
#38 of 158
Health Care
What the data says
Steris's sg&a expense of $1.3B is higher than 76% of companies in the Health Care sector (FY2026). SG&A Expense has fluctuated over the past 9 years, ranging from $670M in FY2021 to $1.3B in FY2024.
Based on SEC 10-K filings.
$1.3B in FY2026 with a 5-year CAGR of +13.3%. Top quartile in the Health Care sector.
Improved from $1.3B to $1.3B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 158This company $1.3B Sector average $175.9B
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.3%, indicating consistent growth.
- In FY2026, sg&a expense increased 14.8% year-over-year.
- Ranks #38 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.3B | +14.8% |
| FY2025 | $1.1B | -18.3% |
| FY2024 | $1.3B | +6.5% |
| FY2023 | $1.3B | +74.7% |
| FY2022 | $716.7M | +7.0% |
| FY2021 | $669.9M | -8.4% |
| FY2020 | $731.3M | +7.2% |
| FY2019 | $682.0M | +1.8% |
| FY2018 | $669.9M | - |
| FY2017 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026